Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma

NCT: NCT07118202 · RECRUITING

NCT IDNCT07118202
StatusRECRUITING
Start Date2025-10-20
Completion2028-08-31

Brief Summary

The goal of this clinical trial is to learn if the TheraBionic P1 device given to patients with advanced hepatocellular carcinoma (HCC) who have no standard of care options can affect patients survival. The main questions it aims to answer are: * will the TheraBionic P1 device affect overall survival in advance HCC * the long term safety and tolerability of the TheraBionic P1 device * assessment of how the disease responded to the TheraBionic P1 device

Frequently Asked Questions

What is TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma?

TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma is a clinical trial registered under NCT07118202. Current status: RECRUITING.

What is the status of NCT07118202?

The current status of NCT07118202 (TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma) is: RECRUITING.

When did TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma start?

TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma started on 2025-10-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑